Eduardo Rene Salas's most recent trade in Adma Biologics Inc was a trade of 16,279 Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adma Biologics Inc | Eduardo Rene Salas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 16,279 | 16,279 | - | - | Stock Option (right to buy) | |
| Adma Biologics Inc | Eduardo Rene Salas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 10,889 | 10,889 (0%) | 0% | 0 | Common Stock | |
| Adma Biologics Inc | Eduardo Rene Salas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2024 | 20,011 | 20,011 | - | - | Stock Option (right to buy) | |
| IntraCellular Therapies Inc | Eduardo Rene Salas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2024 | 1,567 | 0 | - | - | Restricted Stock Units | |
| IntraCellular Therapies Inc | Eduardo Rene Salas | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2024 | 1,567 | 1,567 (0%) | 0% | - | Common Stock | |
| IntraCellular Therapies Inc | Eduardo Rene Salas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 4,322 | 4,322 | - | - | Stock Option (right to buy) | |
| IntraCellular Therapies Inc | Eduardo Rene Salas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 2,951 | 2,951 | - | - | Restricted Stock Units | |
| IntraCellular Therapies Inc | Eduardo Rene Salas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 7,009 | 7,009 | - | - | Stock Option (right to buy) | |
| IntraCellular Therapies Inc | Eduardo Rene Salas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 1,567 | 1,567 | - | - | Restricted Stock Units | |
| IntraCellular Therapies Inc | Eduardo Rene Salas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 16,757 | 16,757 | - | - | Stock Option (right to buy) | |
| IntraCellular Therapies Inc | Eduardo Rene Salas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |